Latest filings (excl ownership)
15-12G
Securities registration termination
14 Dec 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
Submission of Matters to a Vote of Security Holders
28 Oct 22
DEFM14A
Proxy related to merger
30 Sep 22
8-K
Regulation FD Disclosure
21 Sep 22
DEFA14A
Additional proxy soliciting materials
21 Sep 22
PREM14A
Preliminary proxy related to merger
16 Sep 22
253G2
Offering circular supplement
7 Sep 22
8-K
Entry into a Material Definitive Agreement
7 Sep 22
DEFA14A
Additional proxy soliciting materials
7 Sep 22
8-K
Termination of a Material Definitive Agreement
22 Aug 22
DEFA14A
Additional proxy soliciting materials
22 Aug 22
UPLOAD
Letter from SEC
15 Aug 22
CORRESP
Correspondence with SEC
8 Aug 22
UPLOAD
Letter from SEC
4 Aug 22
CORRESP
Correspondence with SEC
3 Aug 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
UPLOAD
Letter from SEC
20 Jul 22
CORRESP
Correspondence with SEC
7 Jul 22
8-K
Regulation FD Disclosure
6 Jul 22
DEFA14A
Additional proxy soliciting materials
6 Jul 22
UPLOAD
Letter from SEC
23 Jun 22
RW
Registration withdrawal request
14 Jun 22
CORRESP
Correspondence with SEC
9 Jun 22
UPLOAD
Letter from SEC
27 May 22
S-1/A
IPO registration (amended)
23 May 22
8-K
Option agreement comprises three technologies and associated patent portfolios
17 May 22
DEFA14A
Additional proxy soliciting materials
17 May 22
10-Q
2022 Q1
Quarterly report
12 May 22
8-K
Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement
19 Apr 22
8-K
Entry into a Material Definitive Agreement
12 Apr 22
8-K
Departure of Directors or Certain Officers
5 Apr 22
10-K
2021 FY
Annual report
11 Mar 22
8-K
Entry into a Material Definitive Agreement
25 Feb 22
S-1
IPO registration
4 Feb 22
8-K
Entry into a Material Definitive Agreement
27 Dec 21
253G1
Information omitted from offering circular
6 Dec 21
QUALIF
Notice of qualification
6 Dec 21
CORRESP
Correspondence with SEC
1 Dec 21
UPLOAD
Letter from SEC
24 Nov 21